Twist Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2021 Annual Meeting of Stockholders held on February 3, 2021. The filing covers the voting outcomes for four proposals submitted to shareholders of Twist Bioscience Corporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
Shareholders representing approximately 92.22% of eligible outstanding shares (44,838,039 shares) participated in the meeting. The following proposals were approved:
- Proposal One (Election of Directors): Stockholders elected three Class III Directors: Emily M. Leproust, Ph.D., William Banyai, Ph.D., and Robert Chess.
- Proposal Two (Say-on-Pay): Stockholders approved the non-binding advisory vote on executive compensation with 35,928,044 votes for and 4,068,960 votes against.
- Proposal Three (Say-on-Pay Frequency): Stockholders selected an annual frequency for future advisory votes on executive compensation, with 38,876,456 votes for a 1-year cycle.
- Proposal Four (Auditor Ratification): Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered accounting firm for the fiscal year ending September 30, 2021.
Guidance, Outlook, and Management Commentary
Based on the voting results for Proposal Three, the Board of Directors determined that non-binding advisory votes on executive compensation will be submitted to stockholders every year until the next required frequency vote under Section 14A(a)(2) of the Securities Exchange Act of 1934. The filing contains no financial guidance, risk factors, or unusual items.
Key Facts for Investor Verification
- Verify the official board composition following the election of the three new Class III Directors.
- Confirm the annual cadence for future executive compensation advisory votes as mandated by the shareholder decision.
- Note the high level of shareholder participation (92.22%) and the strong support for the ratification of PricewaterhouseCoopers LLP.